BTF Overview
- Founded
- 1999
- Status
- Acquired/Merged
- Employees
- 24
- Latest Deal Type
- M&A
BTF General Information
Description
Manufacturer and supplier of quantitative biological reference materials and standards for the life sciences sector. The company provides reference samples for analytical laboratories to use in the quality control of their testing processes.
Contact Information
Website
www.btfbio.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Office
- PO Box 599
- North Ryde, New South Wales 1670
- Australia
+61 (02) 0000 0000
BTF Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 11-Sep-2007 | 00.000 | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 03-Oct-2005 | 00.000 | Completed | Startup | ||
| 1. Seed Round | 15-Jul-2005 | $2.23M | $2.23M | 00.000 | Completed | Startup |
BTF Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| SERIES A PREFERENCE | 00,000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
BTF Patents
BTF Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019100522-A4 | Vial stopper | Active | 29-Jun-2018 | 0000000000 | |
| US-20030049717-A1 | Preparation of fluorescent biopolymers; obtain biopolymers sample, analyze, form frozen spheres, freeze dry spheres to form product | Granted | 12-Sep-2001 | 00000000 | 0 |
| US-6780581-B2 | Preparation of fluorescent biopolymers; obtain biopolymers sample, analyze, form frozen spheres, freeze dry spheres to form product | Expired - Lifetime | 12-Sep-2001 | 00000000 | 0 |
| AU-PQ629100-A0 | Process for preparing controlled samples of particles such as microorganisms and cells | Abandoned | 16-Mar-2000 | 00000000 | |
| DE-60143289-D1 | Method for producing control samples of particles such as microorganisms and cells | Expired - Lifetime | 16-Mar-2000 | C12Q1/02 |
BTF Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Graham Vesey Ph.D | Co-Founder & Chief Technology Officer | ||
| Mark Gauci | Co-Founder & Chief Executive Officer |
BTF Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialBTF Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Kestrel Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Pittsburgh Life Sciences Greenhouse | Venture Capital | Minority | 000 0000 | 000000 0 |